S&P 500 Futures
(0.27%) 5 145.50 points
Dow Jones Futures
(0.28%) 38 549 points
Nasdaq Futures
(0.38%) 17 913 points
Oil
(-0.83%) $83.15
Gas
(1.30%) $1.948
Gold
(-0.09%) $2 345.00
Silver
(1.19%) $27.58
Platinum
(0.64%) $928.00
USD/EUR
(-0.27%) $0.932
USD/NOK
(-0.21%) $11.00
USD/GBP
(-0.36%) $0.797
USD/RUB
(0.87%) $92.68

Actualizaciones en tiempo real para Mesa Laboratories Inc [MLAB]

Bolsa: NASDAQ Sector: Technology Industria: Scientific & Technical Instruments
BUY
50.00%
return 0.40%
SELL
0.00%
return 3.58%
Última actualización26 abr 2024 @ 16:00

1.37% $ 103.19

VENDER 107456 min ago

@ $92.30

Emitido: 14 feb 2024 @ 09:40


Retorno: 11.80%


Señal anterior: feb 13 - 09:30


Señal anterior: Comprar


Retorno: 0.53 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally...

Stats
Volumen de hoy 18 627.00
Volumen promedio 43 153.00
Capitalización de mercado 556.61M
EPS $0 ( 2024-02-05 )
Próxima fecha de ganancias ( $2.33 ) 2024-05-24
Last Dividend $0.160 ( 2023-11-29 )
Next Dividend $0 ( N/A )
P/E 607.00
ATR14 $0.499 (0.48%)
Insider Trading
Date Person Action Amount type
2024-04-02 Sullivan John James Sell 450 Non Qualified Stock Option
2024-04-02 Sakys John Sell 2 500 Non Qualified Stock Option
2024-04-02 Owens Gary M Sell 5 000 Non Qualified Stock Options
2024-04-02 Archbold Brian David Sell 420 Non Qualified Stock Option
2024-01-08 Archbold Brian David Sell 290 Non Qualified Stock Option
INSIDER POWER
12.65
Last 100 transactions
Buy: 73 301 | Sell: 52 584

Mesa Laboratories Inc Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Mesa Laboratories Inc Finanzas

Annual 2023
Ingresos: $219.08M
Beneficio Bruto: $133.69M (61.02 %)
EPS: $0.170
FY 2023
Ingresos: $219.08M
Beneficio Bruto: $133.69M (61.02 %)
EPS: $0.170
FY 2022
Ingresos: $184.34M
Beneficio Bruto: $109.09M (59.18 %)
EPS: $0.360
FY 2021
Ingresos: $133.94M
Beneficio Bruto: $87.01M (64.97 %)
EPS: $0.660

Financial Reports:

No articles found.

Mesa Laboratories Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.160
(N/A)
$0.160
(N/A)
$0.160
(N/A)
$0.160
(N/A)
$0.160
(N/A)
$0.160
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Mesa Laboratories Inc Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.61 - good (76.09%) | Divividend Growth Potential Score: 5.87 - Stable (17.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.200 2003-11-26
Last Dividend $0.160 2023-11-29
Next Dividend $0 N/A
Payout Date 2023-12-15
Next Payout Date N/A
# dividends 81 --
Total Paid Out $11.06 --
Avg. Dividend % Per Year 0.19% --
Score 4.41 --
Div. Sustainability Score 7.61
Div.Growth Potential Score 5.87
Div. Directional Score 6.74 --
Next Divdend (Est)
(2024-07-01)
$0.164 Estimate 39.63 %
Dividend Stability
0.79 Good
Dividend Score
4.41
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2003 $0.200 3.07%
2004 $0.410 4.07%
2005 $0.500 3.85%
2006 $0.390 2.60%
2007 $0.340 1.80%
2008 $0.400 1.54%
2009 $0.410 2.27%
2010 $0.450 1.70%
2011 $0.490 1.63%
2012 $0.530 1.29%
2013 $0.570 1.08%
2014 $0.610 0.79%
2015 $0.640 0.80%
2016 $0.640 0.64%
2017 $0.640 0.52%
2018 $0.640 0.51%
2019 $0.640 0.31%
2020 $0.640 0.26%
2021 $0.640 0.23%
2022 $0.640 0.20%
2023 $0.640 0.37%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.004451.5009.9110.00[0 - 0.5]
returnOnAssetsTTM0.001281.2009.9610.00[0 - 0.3]
returnOnEquityTTM0.002411.500-1.084-1.626[0.1 - 1]
payoutRatioTTM3.63-1.00010.00-10.00[0 - 1]
currentRatioTTM2.680.8001.6061.285[1 - 3]
quickRatioTTM1.5030.8005.874.69[0.8 - 2.5]
cashRatioTTM0.6391.5007.5610.00[0.2 - 2]
debtRatioTTM0.318-1.5004.70-7.04[0 - 0.6]
interestCoverageTTM-2.031.000-1.862-1.862[3 - 30]
operatingCashFlowPerShareTTM8.122.007.2910.00[0 - 30]
freeCashFlowPerShareTTM7.552.006.2310.00[0 - 20]
debtEquityRatioTTM0.586-1.5007.66-10.00[0 - 2.5]
grossProfitMarginTTM0.6101.0003.163.16[0.2 - 0.8]
operatingProfitMarginTTM-0.04381.000-2.88-2.88[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1851.000-0.0812-0.0812[0.2 - 2]
assetTurnoverTTM0.2870.800-1.420-1.136[0.5 - 2]
Total Score7.61

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM587.031.00010.000[1 - 100]
returnOnEquityTTM0.002412.50-0.697-1.626[0.1 - 1.5]
freeCashFlowPerShareTTM7.552.007.4810.00[0 - 30]
dividendYielPercentageTTM0.6201.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.122.007.2910.00[0 - 30]
payoutRatioTTM3.631.50010.00-10.00[0 - 1]
pegRatioTTM1.6931.5002.050[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2061.0007.360[0.1 - 0.5]
Total Score5.87

Mesa Laboratories Inc

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico